COMP <GO>
ALG vs TMO // RSI-14 & 200D SMA MOMENTUM
Alamo Group Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ALG 6
— TMO 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: TMO
LAST: $146.74 (+1.70%) • MKT CAP: $1.79B
rsi-technicals
38.7
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
rsi-technicals
62.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALG VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALG | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 24.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 14.30% | 9.30% | +5.00 | ALG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.3x | 30.4x | -22.10 | ALG | /valuation <GO> |
| Free Cash Flow Yield | 8.23% | 2.40% | +5.83 | ALG | /fcf-yield <GO> |
| Operating Margin | 9.50% | 17.40% | -7.90 | TMO | /operating-margins <GO> |
| Net Profit Margin | 6.50% | 15.10% | -8.60 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | -1.50% | 3.90% | -5.40 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.81% | 0.24% | +0.57 | ALG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.14 | 4.50 | +0.64 | ALG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 8/9 | -3.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 38.7 | 62.9 | -24.18 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.0x | 36.3x | -20.30 | ALG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.79B | $262.22B | -$260.43B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALG REV | TMO REV | ALG GROSS % | TMO GROSS % | ALG FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.60B | $44.56B | 24.8% | — | $146.9M | $6.29B |
| FY 2024 | $1.63B | $42.88B | 25.3% | — | $184.8M | $7.27B |
| FY 2023 | $1.69B | $42.86B | — | — | $131.2M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALG // BETA —
TMO // BETA 0.94